Coxiella burnetii Endocarditis and Meningitis, California, USA, 2017

Emerg Infect Dis. 2018 Aug;24(8):1555-1557. doi: 10.3201/eid2408.180249.

Abstract

The epidemiology of Coxiella burnetii infection in the United States is not well characterized. We report a case-patient with C. burnetii endocarditis and meningitis. Infection was diagnosed by detecting high serologic titers for C. burnetii and confirmed by sequencing of C. burnetii 16S rRNA isolated from resected valvular tissue and PCR of cerebrospinal fluid.

Keywords: California; Coxiella burnetii; Q fever; United States; bacteria; endocarditis; epidemiology; human infection; meningitis; meningitis/encephalitis.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Bacterial / blood
  • California / epidemiology
  • Coxiella burnetii / isolation & purification*
  • Doxycycline / administration & dosage
  • Doxycycline / therapeutic use
  • Endocarditis, Bacterial / epidemiology
  • Endocarditis, Bacterial / microbiology*
  • Endocarditis, Bacterial / therapy
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Hydroxychloroquine / therapeutic use
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Male
  • Meningitis, Bacterial / epidemiology
  • Meningitis, Bacterial / microbiology*
  • Q Fever / epidemiology*
  • Q Fever / pathology*
  • RNA, Bacterial / genetics
  • RNA, Ribosomal, 16S / genetics

Substances

  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Immunoglobulin G
  • Immunoglobulin M
  • RNA, Bacterial
  • RNA, Ribosomal, 16S
  • Hydroxychloroquine
  • Doxycycline